Fulcrum Therapeutics Cut to Neutral From Overweight by Cantor Fitzgerald
Fulcrum Therapeutics Cut to Underperform From Neutral by B of A Securities
Interpublic Cut to Sell From Neutral by UBS
Micron Technology Cut to Underperform From Outperform by Exane BNP Paribas
Oncternal Therapeutics Cut to Hold From Buy by Brookline Capital
Oncternal Therapeutics Cut to Market Perform From Outperform by Northland Capital Markets
PotlatchDeltic Raised to Buy From Neutral by B of A Securities
Roku Raised to Outperform From Peer Perform by Wolfe Research
Simon Property Cut to Hold From Buy by Stifel
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
September 13, 2024 06:12 ET (10:12 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。